510(k) Predicate, Labeling Questions Arise At Institute Of Medicine Meeting
This article was originally published in The Gray Sheet
Executive Summary
Questions about 510(k) labeling changes, device modifications and third-party reviews are among those being raised by an Institute of Medicine task force commissioned to review FDA's 510(k) pre-market submissions program